Diagnostics · 2021 · 14 citations · 18 references
Life SciencesGeneticsOncologyApoptosisCancer GeneticsMolecular OncologyApoptosis In CancerApoptosis RegulationBreast Cancer OncologyCancer Cell SignalingCancer GenomicsMalignant NeoplasmsApoptosis Pathway GenesApoptosis Regulation GenesApoptosis Signaling In CancerP53 MutationP53-mediated ApoptosisP53-mediated Cell Cycle RegulationTp53 MutationsTumor Suppressor P53
Breast cancer is one of the most common oncological diseases among women worldwide. Cell cycle and apoptosis—related genes TP53, BBC3, CCND1 and EGFR play an important role in the pathogenesis of breast cancer. However, the roles of single nucleotide polymorphisms (SNPs) in these genes have not been fully defined. Therefore, this study aimed to analyze the association between TP53 rs1042522, BBC3 rs2032809, CCND1 rs9344 and EGFR rs2227983 polymorphisms and breast cancer phenotype and prognosis. For the purpose of the analysis, 171 Lithuanian women were enrolled. Genomic DNA was extracted from peripheral blood; PCR-RFLP was used for SNPs analysis. The results showed that BBC3 rs2032809 was associated with age at the time of diagnosis, disease progression, metastasis and death. CCND1 rs9344 was associated with tumor size, however an association resulted in loss of significance after Bonferroni correction. In survival analysis, significant associations were observed between BBC3 rs2032809 and OS, PFS and MFS. EGFR rs2227983 also showed some associations with OS and PFS (univariate Cox regression analysis). However, the results were in loss of significance (multivariate Cox regression analysis). In conclusion, BBC3 rs2032809 polymorphism was associated with breast cancer phenotype and prognosis. Therefore, it could be applied as potential markers for breast cancer prognosis.
18
Tetsuya Moriai, Michael S. Kobrin, Christopher M. Hope et al. · Proceedings of the National Academy of Sciences · 1994 · 137 citations
CCND1 Splice Variant as A Novel Diagnostic and Predictive Biomarker for Thyroid Cancer
Sora Jeon, Yourha Kim, Young Mun Jeong et al. · Cancers · 2018 · 45 citations · Full text
Yao‐Yu Hsieh, Cheng‐Hwai Tzeng, Ming‐Huang Chen et al. · Cancer Science · 2012 · 34 citations · Full text
Medicine, Oncology, Pharmacology +17